- Home
- HESM vs TMDX Comparison
HESM vs TMDX Comparison
Compare HESM & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HESM
- TMDX
- Stock Information
- Founded
- HESM 2014
- TMDX 1998
- Country
- HESM United States
- TMDX United States
- Employees
- HESM N/A
- TMDX N/A
- Industry
- HESM Oil & Gas Production
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HESM Energy
- TMDX Health Care
- Exchange
- HESM Nasdaq
- TMDX Nasdaq
- Market Cap
- HESM 4.3B
- TMDX 4.0B
- IPO Year
- HESM N/A
- TMDX 2019
- Fundamental
- Price
- HESM $33.91
- TMDX $119.03
- Analyst Decision
- HESM Hold
- TMDX Buy
- Analyst Count
- HESM 9
- TMDX 11
- Target Price
- HESM $41.44
- TMDX $130.73
- AVG Volume (30 Days)
- HESM 1.6M
- TMDX 1.1M
- Earning Date
- HESM 11-03-2025
- TMDX 10-29-2025
- Dividend Yield
- HESM 8.90%
- TMDX N/A
- EPS Growth
- HESM 18.65
- TMDX 170.70
- EPS
- HESM 2.81
- TMDX 2.54
- Revenue
- HESM $1,613,000,000.00
- TMDX $566,354,000.00
- Revenue This Year
- HESM $12.47
- TMDX $38.84
- Revenue Next Year
- HESM $4.22
- TMDX $20.46
- P/E Ratio
- HESM $12.08
- TMDX $46.95
- Revenue Growth
- HESM 10.78
- TMDX 41.20
- 52 Week Low
- HESM $31.63
- TMDX $55.00
- 52 Week High
- HESM $44.14
- TMDX $145.50
- Technical
- Relative Strength Index (RSI)
- HESM 46.98
- TMDX 44.82
- Support Level
- HESM $33.01
- TMDX $119.20
- Resistance Level
- HESM $35.40
- TMDX $128.09
- Average True Range (ATR)
- HESM 0.68
- TMDX 7.95
- MACD
- HESM 0.20
- TMDX -0.93
- Stochastic Oscillator
- HESM 41.57
- TMDX 12.28
About HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.